Shares of Centene Corporation (NYSE:CNC – Get Free Report) gapped up prior to trading on Monday. The stock had previously closed at $71.27, but opened at $74.04. Centene shares last traded at $75.0510, with a volume of 657,871 shares changing hands.
Analyst Ratings Changes
Several brokerages have recently commented on CNC. Wall Street Zen cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 31st. UBS Group increased their price target on shares of Centene from $70.00 to $78.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 28th. Raymond James Financial set a $79.00 price objective on shares of Centene in a research note on Wednesday, October 28th. Cantor Fitzgerald boosted their price objective on shares of Centene from $75.00 to $79.00 and gave the company an “overweight” rating in a research report on Wednesday, October 28th. Finally, Zacks Research cut Centene from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Nine research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $73.80.
Centene Price Performance
The business’s fifty day moving average price is $67.07 and its 200 day moving average price is $56.51. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market cap of $36.85 billion, a P/E ratio of 25.50, a PEG ratio of 0.42 and a beta of 1.07.
Centene (NYSE:CNC – Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.48. The company had revenue of $50.65 billion for the quarter, compared to analyst estimates of $47.12 billion. Centene had a net margin of 0.72% and a return on equity of 12.15%. The firm’s revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.50 EPS. Sell-side analysts forecast that Centene Corporation will post 5.27 EPS for the current fiscal year.
Insider Buying and Selling at Centene
In related news, General Counsel Christopher Koster sold 56,500 shares of the business’s stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total value of $3,779,850.00. Following the sale, the general counsel owned 248,854 shares of the company’s stock, valued at $16,648,332.60. The trade was a 18.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.37% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Centene
A number of hedge funds and other institutional investors have recently made changes to their positions in CNC. Cetera Investment Advisers increased its position in shares of Centene by 22.1% during the third quarter. Cetera Investment Advisers now owns 146,840 shares of the company’s stock worth $9,122,000 after buying an additional 26,595 shares during the period. Empirical Finance LLC raised its stake in Centene by 1.7% during the third quarter. Empirical Finance LLC now owns 19,312 shares of the company’s stock worth $1,200,000 after buying an additional 318 shares during the last quarter. FORA Capital LLC lifted its holdings in Centene by 555.6% in the third quarter. FORA Capital LLC now owns 256,437 shares of the company’s stock valued at $15,935,000 after buying an additional 217,325 shares during the period. Pathstone Holdings LLC lifted its holdings in Centene by 33.1% in the third quarter. Pathstone Holdings LLC now owns 78,737 shares of the company’s stock valued at $4,929,000 after buying an additional 19,572 shares during the period. Finally, Empowered Funds LLC boosted its position in Centene by 109.9% during the third quarter. Empowered Funds LLC now owns 464,020 shares of the company’s stock valued at $28,825,000 after acquiring an additional 242,914 shares during the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.
Centene Company Profile
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
Recommended Stories
- Five stocks we like better than Centene
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
